Literature DB >> 7751404

Antisense suppression of skeletal muscle myosin light chain-1 biosynthesis impairs myofibrillogenesis in cultured myotubes.

R Nawrotzki1, D A Fischman, T Mikawa.   

Abstract

Although the alkali or essential light chains of skeletal muscle myosin are not required for actin-activated myosin ATPase activity, these myosin subunits are necessary for force transmission with in vitro actin motility assays and are believed to stabilize the alpha-helical neck region of myosin subfragment-1. To probe the functions of the essential light chains during myofibril assembly, we used recombinant DNA procedures to deplete this light chain in cultured muscle. Retroviral expression vectors were constructed which encoded the exon-1 sequence of the myosin light chain-1 gene in antisense orientation. These vectors were applied to myogenic cells from embryonic chick and quail pectoralis muscle. Colonies expressing antisense RNA were selected in growth medium containing the neomycin analogue G-418, plus 5-bromo-2'-deoxyuridine (BrdU) and triggered to differentiate by removal of the latter. Expression of antisense myosin light chain-1 mRNA impaired muscle development. In the antisense cultures there were more mononucleated cells, fewer and smaller myotubes which had poorly developed myofibrils and high levels of diffusely staining myosin heavy chain, not apparent in control myotubes. Protein synthesis in the myotube cultures was analyzed by 35S-methionine labelling and two-dimensional gel electrophoresis. Except for a suppression of approximately 80% of myosin light chain-1f synthesis, the overall pattern of protein synthesis was not altered significantly. These studies suggest that retardation of myosin light chain-1f accumulation inhibits or delays myofibrillogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751404     DOI: 10.1007/BF00125309

Source DB:  PubMed          Journal:  J Muscle Res Cell Motil        ISSN: 0142-4319            Impact factor:   2.698


  51 in total

1.  Subunit structure of myosin. 3. A proposed model for rabbit skeletal myosin.

Authors:  L C Gershman; A Stracher; P Dreizen
Journal:  J Biol Chem       Date:  1969-05-25       Impact factor: 5.157

2.  Substructure of the myosin molecule. II. The light chains of myosin.

Authors:  A G Weeds; S Lowey
Journal:  J Mol Biol       Date:  1971-11-14       Impact factor: 5.469

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Monoclonal antibodies to desmin: evidence for stage-dependent intermediate filament immunoreactivity during cardiac and skeletal muscle development.

Authors:  D A Fischman; S I Danto
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

5.  Alternative transcription and two modes of splicing results in two myosin light chains from one gene.

Authors:  Y Nabeshima; Y Fujii-Kuriyama; M Muramatsu; K Ogata
Journal:  Nature       Date:  1984 Mar 22-28       Impact factor: 49.962

6.  cDNA recombinant plasmid complementary to mRNAs for light chains 1 and 3 of mouse skeletal muscle myosin.

Authors:  B Robert; A Weydert; M Caravatti; A Minty; A Cohen; P Daubas; F Gros; M Buckingham
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

7.  Gene expression of myofibrillar proteins in single muscle fibers of adult chicken: micro two dimensional gel electrophoretic analysis.

Authors:  T Mikawa; S Takeda; T Shimizu; T Kitaura
Journal:  J Biochem       Date:  1981-06       Impact factor: 3.387

8.  A correlation of various small sub-units of myosin.

Authors:  R H Locker; C J Hagyard
Journal:  Arch Biochem Biophys       Date:  1967-04       Impact factor: 4.013

9.  Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNA.

Authors:  S K Kim; B J Wold
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

10.  Myosin light chains and the developmental origin of fast muscle.

Authors:  F E Stockdale; N Raman; H Baden
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  6 in total

1.  Retroviral techniques for studying organogenesis with a focus on heart development.

Authors:  J Hyer; T Mikawa
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

2.  Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization.

Authors:  Laura T Donlin; Christian Andresen; Steffen Just; Eugene Rudensky; Christopher T Pappas; Martina Kruger; Erica Y Jacobs; Andreas Unger; Anke Zieseniss; Marc-Werner Dobenecker; Tobias Voelkel; Brian T Chait; Carol C Gregorio; Wolfgang Rottbauer; Alexander Tarakhovsky; Wolfgang A Linke
Journal:  Genes Dev       Date:  2012-01-12       Impact factor: 11.361

3.  Alteration of tropomyosin-binding properties of tropomodulin-1 affects its capping ability and localization in skeletal myocytes.

Authors:  Natalia A Moroz; Stefanie M Novak; Ricardo Azevedo; Mert Colpan; Vladimir N Uversky; Carol C Gregorio; Alla S Kostyukova
Journal:  J Biol Chem       Date:  2012-12-27       Impact factor: 5.157

4.  Nebulin regulates actin filament lengths by a stabilization mechanism.

Authors:  Christopher T Pappas; Paul A Krieg; Carol C Gregorio
Journal:  J Cell Biol       Date:  2010-05-24       Impact factor: 10.539

5.  Bi-allelic mutations in MYL1 cause a severe congenital myopathy.

Authors:  Gianina Ravenscroft; Irina T Zaharieva; Carlo A Bortolotti; Matteo Lambrughi; Marcello Pignataro; Marco Borsari; Caroline A Sewry; Rahul Phadke; Goknur Haliloglu; Royston Ong; Hayley Goullée; Tamieka Whyte; Uk K Consortium; Adnan Manzur; Beril Talim; Ulkuhan Kaya; Daniel P S Osborn; Alistair R R Forrest; Nigel G Laing; Francesco Muntoni
Journal:  Hum Mol Genet       Date:  2018-12-15       Impact factor: 6.150

6.  Altered miRNA and mRNA Expression in Sika Deer Skeletal Muscle with Age.

Authors:  Boyin Jia; Yuan Liu; Qining Li; Jiali Zhang; Chenxia Ge; Guiwu Wang; Guang Chen; Dongdong Liu; Fuhe Yang
Journal:  Genes (Basel)       Date:  2020-02-06       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.